-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Poor
sores or irritation in the calendar year
63.7
84.0
24.2%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
61.3
84.2
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Middle_Income
Benchmark
Measure
Estimate
Benchmark
Distance to Benchmark
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
75.4
84.2
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Low_Income
received a mammogram in the last 2 years
68.5
84.7
19.1%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
66.3
84.2
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/High_Income
doses of polio vaccine
95.9
97.3
Achieved within: 1.4%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
82.7
84.2
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Young_Adults
the last 2 months of care
Ages 18-44
32.3
35.9
10.1%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Ages 21-44
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Middle_Income
Measure
Population
Estimate
Benchmark
Distance to Benchmark
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Middle
75.4
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Residents_of_Rural_Areas
February 19, 2021 - meningococcal conjugate vaccine
Nonmetropolitan
84.9
95.4
11.0%
Women ages 21-65 who received a Pap … smear in the last 3 years
Micropolitan (nonmetro)
74.3
84.2
11.8%
Adults age 40 and over
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Low_Income
February 19, 2021 - mammogram in the last 2 years
Near poor/low
68.5
84.7
19.1%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Near poor/low
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/High_Income
February 19, 2021 - of polio vaccine
High
95.9
97.3
Achieved within: 1.4%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
High
82.7
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Middle_Aged_Adults
among reporting jurisdictions
Ages 45-54
58.6
66.2
11.5%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Ages 45-65
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Poor
irritation in the calendar year
Negative/poor
63.7
84.0
24.2%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Negative/poor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Non-Hispanic_White
February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Deaths per 1,000
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Hispanic
February 19, 2021 - Adults with limited English proficiency who had a usual source of care
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Deaths per 1,000
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Asian
February 19, 2021 - Adults with limited English proficiency who had a usual source of care
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Lung cancer deaths
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Multiple_Races
of care
Multiple races
87.9
94.0
Achieved within: 6.5%
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Multiple races
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Female
Deaths per 1,000 hospital admissions with expected low-mortality
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Deaths per 1,000
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Women
February 19, 2021 - months who sometimes or never found it easy to see a specialist 2.6
Women ages 21-65 who received a Pap … smear in the last 3 years 2.7
Home health care patients who had an emergency department visit without
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Black
February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Deaths per 1,000
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Women
February 19, 2021 - breast within 1 year of diagnosis
Total
92.1
96.2
4.2%
Women ages 21-65 who received a Pap … smear in the last 3 years
Total
80.5
84.2
4.4%
Children ages 19-35 months who received
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/All_Measures/All_Topics
February 19, 2021 - Deaths per 1,000 hospital admissions with expected low-mortality
Women ages 21-65 who received a Pap … smear in the last 3 years or human papillomavirus vaccines (HPV) in the last 5 years
Deaths per 1,000